VVP
DXCM icon

Venture Visionary Partners’s DexCom DXCM Stock Holding History

Venture Visionary Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,590
Closed -$119K – 761
2022
Q2 		$119K Sell
1,590
-374
-19% -$34.1K 0.01% 559
2022
Q1 		$251K Buy
1,964
+8
+0.4% +$875 0.02% 442
2021
Q4 		$262K Buy
1,956
+188
+11% +$27K 0.02% 437
2021
Q3 		$244K Buy
+1,768
New +$223K 0.02% 447
2021
Q2 		– Sell
-4,908
Closed -$440K – 504
2021
Q1 		$440K Buy
4,908
+632
+15% +$59.3K 0.04% 314
2020
Q4 		$395K Buy
+4,276
New +$382K 0.04% 274

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Venture Visionary Partners's DXCM Position: Q3 2022 in Review

Venture Visionary Partners sold out of DexCom (DXCM) in Q3 2022, closing a stake of 1,590 shares — an estimated $119K sold.

Venture Visionary Partners first reported a position in DXCM in Q4 2020 and held it in 6 quarters. The position peaked at $440K in Q1 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Venture Visionary Partners reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 1,590 DexCom shares in Q3 2022, an estimated $119K.
  • Venture Visionary Partners first reported a position in DexCom in Q4 2020 and held it in 6 quarters.
  • Venture Visionary Partners's DexCom position peaked at $440K in Q1 2021.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.